A noninvasive method for whole-genome skin methylome profiling

Banila, C et. al., British Journal of Dermatology

Tap into skin epigenetics for clinical success of therapeutics

Measure skin aging inflammation sun damage

Our skin diagnostics platform is proudly supported by these investors and partners

Changing the status quo of skin assessment

Replace invasive biopsies with non-invasive skin testing. Our advanced next-generation sequencing analyzes epigenetics, offering insights into intervention effectiveness, biological aging rate, UV damage, and skin quality metrics to gauge a therapy’s direct impact.

Clinical Trials

Epigenetics biomarkers inform efficacy of skin therapies

Non-Invasive

We use tape-stripping to collect large amounts of biological material easily, and painlessly.

Age-Reversal

By measuring the change in DNA methylation markers, we can assess the skin’s biological age, inflammation, and sun damage.

Precision Therapies

We develop predictive biomarkers, identifying optimal responders to specific formulations. This enables a high level of personalization.

How it works

Design the study and key objectives

Define the key objectives for your clinical trial. Mitra Bio will provide expert guidance to aid you in designing your study.

Collect skin non-invasively

Use Mitra Bio’s proprietary tape strips for comprehensive collection of biological material, in vivo. Send the samples to us and we’ll take care of DNA extraction, targeted next-generation sequencing, full data analysis, and reporting.

Discover actionable insights

Using our extensive database, we help turn epigenetic data into actionable insights for intervention efficacy, dosage and rejuvenation to power precision dermatological therapeutics.

Case Study

Mitra Bio tracks the rejuvenation effect of an Avon product

Join the skin longevity revolution

Subscribe to our free monthly newsletter reviewing the latest age-reversal technologies that we love!